Co-Founders
Richard Skaife
CEO
Has made over 30 investments in emerging biotech and associated ecosystem companies – 10 exits and IPOs from portfolio over last four years.
20 year background in venture building across biotech, fintech, mental health, consumer and business verticals in tech.
Over 100m app downloads, previous board at Pollen VC (exit).
Previously held Partner role at a European VC and CEO of a Venture Builder.
Toby Sorabjee
COO
Former Chief Communications Officer, leading a clinical research company through its IPO process.
Former advisor to HM Treasury and 10 Downing Street on the development and implementation of politically sensitive national policy, including Northern Ireland, EU Exit, and Excise.
Co-Founded and built an EU fund-supported, fully licensed Contract Research Organisation, providing pre-clinical services to emerging pharmaceutical sectors.
Barney Neal
CTO
Co-Founder of a publicly listed drug development company, using big data and real-world evidence to advance novel, next-generation psychotherapeutic drugs to market.
Co-Founder of a major US non-profit association for healthcare professionals.
Built a membership network of thousands of clinicians, focused on bridging the gap between cutting-edge clinical research and standard healthcare practice.
Henri Sant-Cassia
Special Projects
General Partner at a life sciences venture capital fund, where he led investments across the sector – including NASDAQ board positions.
Over two decades of experience in the emerging medicine and life sciences sectors. He has helped build over $200 million in company valuations across biotech and healthcare.
He has worked extensively in the manufacturing, retail, and research of cutting edge products. His expertise spans venture funding, operating models, and media and investor relations.
Specialists
Dr. Javaid Sheikh
Chair of Advisory Board & Investor
Dean of Weill Cornell University – Qatar, a globally renowned leader in population health and medicine.
Established key personalized medicine platforms in genomics and proteomics. Founded the Institute for Population Health, forming the basis for modern healthcare systems across the Middle East.
Formerly a distinguished professor at Stanford University, with extensive publications in top medicine journals.
Jesse Deng
Head of AI
An AI and full stack developer with a Distinction award MSc in Artificial Intelligence and Pharmaceutical Science. His research work focussed on computational drug design for Alzheimer’s disease.
Debbie Eacott
Longr Gulf States
Former Director at a leading UK investment fund focussed on the Gulf States. Specializes in market entry strategies, with a proven track record in Manufacturing, Distribution, and Investor Representation.
Prof. Suran Goonatilake
ML Advisor
OBE Professor at University College London. CEO and Co-Founder of Bodymetrics, revolutionizing body-mapping technology. A Co-Founder of Big-Data company, Searchspace, used by global banks and acquired by Warburg Pincus.
Dr. Richard Dallaway
ML Advisor
Expert across drug discovery and financial prediction, leads ML drug discovery and development teams. 30+ year career based on the integration of AI into solving complex problems and developing large-scale software systems.